NCT03659955View on ClinicalTrials.gov

Autologous Blood Treatment for Ocular Surface Disease

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

October 3, 2018

Study Completion Date

March 14, 2019

Conditions
Ocular Surface Disease
Interventions
OTHER

Autologous blood applied to dry eye

See previous description for the study arm.

Trial Locations (1)

G75 8RG

Hairmyres Hospital, East Kilbride

All Listed Sponsors
collaborator

Chief Scientist Office of the Scottish Government

OTHER_GOV

collaborator

NHS Research Scotland

OTHER

lead

NHS Lanarkshire

OTHER_GOV

NCT03659955 - Autologous Blood Treatment for Ocular Surface Disease | Biotech Hunter | Biotech Hunter